UCSF CME: 10th Annual California Heart Rhythm Symposium (Videos)

Atrial Fibrillation

Understanding Atrial Fibrillation

• Mechanism of Atrial Fibrillation

• Unveiling the intricacies of atrial fibrillation through advanced imaging and mapping techniques.

• Risk Factors and Prevention

• Exploring the key factors associated with atrial fibrillation and uncovering strategies for reducing its occurrence.

• Catheter Ablation

• Assessing the effectiveness of catheter ablation in preventing dementia and its implications for patient care.

• Anticoagulation

• Evaluating the benefits and risks of anticoagulation in low-risk individuals with atrial fibrillation.

• Ablation Techniques

• Comparing the outcomes and approaches of cryoballoon ablation versus radiofrequency ablation for atrial fibrillation.

• Advanced Ablation Strategies

• Delving into innovative techniques for managing persistent atrial fibrillation beyond pulmonary vein isolation.

• Endocardial versus Epicardial Isolation

• Investigating the role of different ablation methods in targeting the left atrial appendage for optimal outcomes.

• Asymptomatic Atrial Fibrillation

• Uncovering the potential implications and management strategies for asymptomatic atrial fibrillation.

Panel Discussions

• Atrial Fibrillation Panel Discussion
• Engaging experts in a thought-provoking discussion on the latest advances in atrial fibrillation management.

Cardiac Sarcoidosis and ARVD

Pulmonary Evaluation

• Pulmonary Manifestations of Sarcoidosis
• Assessing the respiratory involvement in sarcoidosis and its impact on cardiac function.

Rheumatologic Evaluation and Treatment

• Management of Cardiac Sarcoidosis
• Exploring the role of rheumatologists in diagnosing, treating, and monitoring cardiac sarcoidosis.

Arrhythmogenic Right Ventricular Cardiomyopathy

• Diagnosing ARVD

• Identifying the challenges and nuances of diagnosing arrhythmogenic right ventricular cardiomyopathy accurately.

• ARVD Treatment Options

• Delving into the available therapeutic strategies for managing arrhythmogenic right ventricular cardiomyopathy.

• Ablation Therapy for ARVD

• Evaluating the role of ablation therapy in preventing and treating ventricular arrhythmias in ARVD patients.

Inherited Arrhythmias

• Insights from Sudden Cardiac Death Studies

• Uncovering new perspectives on sudden cardiac death through comprehensive postmortem investigations.

• Brugada Syndrome

• Exploring innovative interventional therapies aimed at eliminating the underlying electrical instability in Brugada syndrome.

• Post-Infarction Management

• Weighing the pros and cons of using a LifeVest for post-infarction patients with reduced ejection fraction.

New Therapies for Heart Failure

Pacing and Implantable Devices

• S-ICD and Novel Pacing Approaches

• Identifying the appropriate indications and techniques for using subcutaneous implantable cardioverter-defibrillators and advanced pacing strategies.

• His Bundle and Left Bundle Branch Pacing

• Assessing the benefits and risks of specialized pacing techniques for managing conduction disorders and heart failure.

Ablation and Device Therapy

• AF and CHF: Ablation as First-Line Therapy

• Examining the potential advantages of ablation therapy as a primary treatment option for atrial fibrillation in heart failure patients.

• ICD Implantation in DCM

• Determining the criteria for implanting an implantable cardioverter-defibrillator in dilated cardiomyopathy patients without evident arrhythmias.

• Wearables and Arrhythmias

• Exploring the emerging role of wearable devices in monitoring and managing arrhythmias in heart failure patients.

Panel Discussions

• New Therapies for Heart Failure Panel Discussion
• Engaging experts in a comprehensive discussion on cutting-edge therapies and future directions in heart failure management.

HIS-Bundle Pacing Debate

• HIS-Bundle Pacing as First-Line Therapy

• Presenting the arguments in favor of HIS-bundle pacing as the preferred treatment for AV block with preserved left ventricular function.

• HIS-Bundle Pacing as Second-Line Therapy

• Counterarguing the use of HIS-bundle pacing as a second-line option, exploring alternative treatments and potential disadvantages.

Ventricular Tachycardia

VT Mechanisms and Localization

• Decoding VT Mechanisms

• Unveiling the underlying electrical mechanisms responsible for various types of ventricular tachycardia.

• ECG Recognition and Localization

• Enhancing diagnostic accuracy by interpreting ECG patterns and localizing the source of idiopathic ventricular tachycardia.

Ablation Strategies

• Mapping and Ablation Techniques

• Sharing pearls and techniques for effectively mapping and ablating left ventricular summit and intramural premature ventricular contractions and ventricular tachycardia.

• Prophylactic Ablation in LVAD Patients

• Exploring the potential benefits and risks of prophylactic ablation in patients receiving left ventricular assist devices.

• Neuromodulatory Therapies

• Investigating the role of novel neuromodulatory approaches in treating and preventing ventricular tachycardia.

Advanced Therapies

• Stereotactic Body Radiation Therapy
• Evaluating the effectiveness of stereotactic body radiation therapy in managing refractory ventricular tachycardia.

Panel Discussions

• “Bailout” Approaches Panel Discussion
• Discussing the advantages and limitations of various “bailout” techniques for managing ventricular tachycardia.

VT Ablation Debate

• VT Ablation as First-Line Therapy

• Advocating for VT ablation as the primary treatment option in patients with monomorphic ventricular tachycardia and no implantable cardioverter-defibrillator.

• VT Ablation as Second-Line Therapy

• Arguing that VT ablation should be considered only after implantable cardioverter-defibrillator implantation in patients with monomorphic ventricular tachycardia.

Rebuttals

• VT Ablation as First-Line Therapy: Rebuttals
• Addressing and countering the arguments against VT ablation as the first-line treatment for monomorphic ventricular tachycardia.